OUR IP & VALUATION BLOG

How to Determine Patent Damages

According to the law, the damage award in a patent infringement action must be “Adequate to compensate for the infringement, but in no event less than a reasonable royalty for the use made of the invention by the infringer, together with interest and costs as fixed by the court.” The

Full Article >>

5 Ideas To Help You Protect Your Trade Secrets

Trade secrets are the building blocks that make your business successful. Trade secrets are intellectual property that you need to first identify and then figure out strategies to keep them protected. A specialized formula, a secret recipe and a unique way you process or make something can be considered a

Full Article >>

Lawsuits Over User-Generated Content (UGC)

User-generated content (UGC) is a valuable part of your company’s content marketing strategy, but it’s also full of potential legal pitfalls. When you’re aware of these liabilities, you’ll have a good grasp of what you can and cannot permit on your sites without risking copyright violations, trademark infringement damages or

Full Article >>

Protecting Your Business Assets and Trademarks

If your plans for 2018 include launching a new product or service, you also want to ensure your business assets and trademarks are protected. Your business relies on its intellectual property, which isn’t a tangible asset but is the sine qua non of your operation. Don’t risk your business by failing to

Full Article >>

Apple vs. Samsung in the Supreme Court

The fight between Apple Inc. and Samsung Electronics Co., the world’s two leading smartphone manufacturers, is not limited to the marketplace – in the past five years, Apple has filed over fifty patent infringement lawsuits internationally against Samsung. The most recent United States ruling was decided in favor of Apple

Full Article >>

Gilead Sciences Loses 200 Million Dollar Case to Merck

Gilead Sciences is a bio-pharmaceutical research and development company that discovers, develops and commercializes innovative medicines in areas of unmet medical need.  Recently, Gilead lost a patent infringement case to Merck, another pharmaceuticals company, and was ordered to pay $200 million in royalties for a pair of hepatitis C drugs,

Full Article >>